Antisense to protein kinase C-alpha and p47phox attenuates the pro-inflammatory effects of human C-reactive protein in macrophages of biobreeding diabetic rats

Diabetes and Vascular Disease Research

Volumn 9, Issue 4, 2012, Pages 315-319

  Jialal, Ishwarlal ^a,b   Devaraj, Sridevi ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

C reactive protein; cytokines; macrophages; p47phox; protein kinase C; superoxide

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; C REACTIVE PROTEIN; HUMAN ALBUMIN; INTERLEUKIN 1; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE C ALPHA; PROTEIN P47; PROTEIN P47PHOX; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOBREEDING RAT; BIOCHEMISTRY; CELL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; ENZYME INHIBITION; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MALE; NONHUMAN; PROTEIN FUNCTION; PROTEIN SECRETION; RAT;

ANIMALS; C-REACTIVE PROTEIN; CHEMOKINE CCL2; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GENETIC THERAPY; HUMANS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1; INTERLEUKIN-6; MACROPHAGES, PERITONEAL; MALE; NADPH OXIDASE; OLIGORIBONUCLEOTIDES, ANTISENSE; PROTEIN KINASE C-ALPHA; RATS; SUPEROXIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866701424     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164112452165     Document Type: Article

References (20)

1. Libby P, Nathan DM, Abraham K, et al. Report of the National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases: working group on cardiovascular complications of type 1 diabetes mellitus. Circulation. 2005 ; 11: 3489-3493
2. Devaraj S, Dasu MR, Jialal I. Diabetes is a pro-inflammatory state: a translational perspective. Expert Rev Endocrinol Metab. 2010 ; 5 (1). 19-28
3. Devaraj S, Cheung AT, Jialal I, et al. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes. 2007 ; 56: 2790-2796
4. Soinio M, Marnemi J, Laakso M, et al. High sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes. Diabetes Care. 2006 ; 29: 329-333
5. Schulze MB, Rimm EB, Li T, et al. C-reactive protein and incident cardiovascular events in diabetes. Diabetes Care. 2004 ; 27: 889-894
6. Devaraj S, Singh U, Jialal I. The evolving role of C-reactive protein in atherothrombosis. Clin Chem. 2009 ; 55: 229-238
7. Verma S, Devaraj S, Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. 2006 ; 113: 2135-2150
8. Schalkwijk CG, Poland DC, Van Dijk W, et al. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia. 1999 ; 42: 351-357
9. Schram MT, Chaturvedi N, Schalkwijk CG, et al. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes-the EURODIAB Prospective Complications Study. Diabetologia. 2005 ; 48: 370-378
10. Devaraj S, Glaser N, Griffen S, et al. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes. 2006 ; 55: 774-779
11. Hayaishi-Okano R, Yamasaki Y, Katakami N, et al. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care. 2002 ; 25: 1432-1438
12. Targher G, Bertolini L, Zoppini G, et al. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med. 2005 ; 22: 999-1004
13. Hansen TK, Forsblom C, Saraheimo M, et al. Association between mannose-binding lectin, high-sensitivity C-reactive protein and the progression of diabetic nephropathy in type 1 diabetes. Diabetologia. 2010 ; 53: 1517-1524
14. Sundell J, Rönnemaa T, Laine H, et al. High-sensitivity C-reactive protein and impaired coronary vasoreactivity in young men with uncomplicated type 1 diabetes. Diabetologia. 2004 ; 47: 1888-1894
15. Bieg S, Koike G, Jiang J, et al. Genetic isolation of iddm 1 on chromosome 4 in the biobreeding (BB) rat. Mamm Genome. 1998 ; 9: 324-326
16. Devaraj S, Dasu MR, Singh U, et al. C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo. Atherosclerosis. 2009 ; 203: 67-74
17. Jialal I, Kaur H, Devaraj S. Human C-reactive protein accentuates macrophage activity in biobreeding diabetic rats. J Diabetes Complications. :
18. Du Clos TW, Zlock LT, Marnell L. Definition of a C-reactive protein binding determinant on histones. J Biol Chem. 1991 ; 266: 2167-2171
19. Dasu MR, Devaraj S, Jialal I. High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am J Physiol Endocrinol Metab. 2007 ; 293: E337 - E446
20. Devaraj S, Venugopal SK, Singh U, et al. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}. Diabetes. 2005 ; 54: 85-91